Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multidrug resistance-associated protein 2 (MRP2), encoded by the ABCC2 gene, is an ATP-dependent efflux transporter primarily localized to the apical (canalicular) membrane of hepatocytes, as well as the apical membranes of renal proximal tubule cells, enterocytes, and syncytiotrophoblasts of the placenta. It plays a critical physiological role in detoxification and tissue protection by mediating the active transport of endogenous substances, such as conjugated bilirubin, sulfated bile salts, and leukotrienes, into bile, urine, or the intestinal lumen. In addition to endogenous metabolites, MRP2 transports a wide variety of xenobiotics and therapeutic drugs, including chemotherapeutic agents (e.g., cisplatin, methotrexate, irinotecan), antivirals, and antibiotics. Overexpression of MRP2 in cancer cells is a major driver of multidrug resistance (MDR), leading to reduced intracellular drug accumulation and chemotherapy failure. Conversely, genetic mutations in ABCC2 cause Dubin-Johnson syndrome, an autosomal recessive disorder characterized by conjugated hyperbilirubinemia. Pharmacological inhibition or modulation of MRP2 can lead to significant drug-drug interactions (DDIs) and toxicities, such as drug-induced liver injury or iatrogenic Fanconi syndrome, making it a key target of interest in pharmacokinetics, toxicology, and oncology.
Drugs target MRP2 either as substrates that are actively effluxed from the cell via ATP hydrolysis, or as inhibitors/modulators that block the transporter's binding pocket to prevent efflux of other drugs, thereby reversing multidrug resistance or causing drug-drug interactions.
15 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multidrug resistance-associated protein 2 (MRP2).